CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Functional Impairment and Medication Burden in Adults With Heart Failure Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure With Preserved Ejection Fraction (REDUCE LAP-HF I [Reduce Elevated Left Atrial Pressure in Patients With Heart Failure]): A Phase 2, Randomized, Sham-Controlled Trial Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone Impact of epicardial adipose tissue on cardiovascular haemodynamics, metabolic profile, and prognosis in heart failure SPECT and PET in ischemic heart failure Heart failure with preserved ejection fraction: from mechanisms to therapies A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)

Review Article2014 Dec 9;130(24):2189-208.

JOURNAL:Circulation. Article Link

Advances in therapeutic interventions for patients with pulmonary arterial hypertension

Humbert M, Lau EM, Montani D et al. Keywords: hypertension, pulmonary; prostaglandins; pulmonary arterial hypertension; pulmonary heart disease; receptors, endothelin; treatment; ventricular remodeling

FULL TEXT PDF